SAB Biotherapeutics, Inc. (SABS)
NASDAQ: SABS · Real-Time Price · USD
3.040
-0.020 (-0.65%)
Nov 21, 2024, 12:56 PM EST - Market open

SAB Biotherapeutics Statistics

Total Valuation

SABS has a market cap or net worth of $28.06 million. The enterprise value is $2.36 million.

Market Cap 28.06M
Enterprise Value 2.36M

Important Dates

The last earnings date was Wednesday, November 6, 2024, after market close.

Earnings Date Nov 6, 2024
Ex-Dividend Date n/a

Share Statistics

SABS has 9.23 million shares outstanding. The number of shares has increased by 74.13% in one year.

Current Share Class 9.23M
Shares Outstanding 9.23M
Shares Change (YoY) +74.13%
Shares Change (QoQ) +0.05%
Owned by Insiders (%) 16.26%
Owned by Institutions (%) 20.53%
Float 6.12M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 17.46
Forward PS n/a
PB Ratio 0.77
P/TBV Ratio 0.77
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 1.56
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.69, with a Debt / Equity ratio of 0.12.

Current Ratio 3.69
Quick Ratio 3.46
Debt / Equity 0.12
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -159.11

Financial Efficiency

Return on equity (ROE) is -174.73% and return on invested capital (ROIC) is -105.52%.

Return on Equity (ROE) -174.73%
Return on Assets (ROA) -78.80%
Return on Capital (ROIC) -105.52%
Revenue Per Employee $26,539
Profits Per Employee -$799,428
Employee Count 57
Asset Turnover 0.04
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -63.96% in the last 52 weeks. The beta is 0.64, so SABS's price volatility has been lower than the market average.

Beta (5Y) 0.64
52-Week Price Change -63.96%
50-Day Moving Average 2.97
200-Day Moving Average 3.53
Relative Strength Index (RSI) 47.55
Average Volume (20 Days) 83,196

Short Selling Information

The latest short interest is 58,763, so 0.64% of the outstanding shares have been sold short.

Short Interest 58,763
Short Previous Month 79,819
Short % of Shares Out 0.64%
Short % of Float 0.96%
Short Ratio (days to cover) 0.54

Income Statement

In the last 12 months, SABS had revenue of $1.51 million and -$45.57 million in losses. Loss per share was -$5.28.

Revenue 1.51M
Gross Profit -25.38M
Operating Income -51.78M
Pretax Income -40.32M
Net Income -45.57M
EBITDA -46.91M
EBIT -51.78M
Loss Per Share -$5.28
Full Income Statement

Balance Sheet

The company has $30.40 million in cash and $4.52 million in debt, giving a net cash position of $25.88 million or $2.80 per share.

Cash & Cash Equivalents 30.40M
Total Debt 4.52M
Net Cash 25.88M
Net Cash Per Share $2.80
Equity (Book Value) 36.90M
Book Value Per Share 4.00
Working Capital 23.72M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$38.21 million and capital expenditures -$349,749, giving a free cash flow of -$38.56 million.

Operating Cash Flow -38.21M
Capital Expenditures -349,749
Free Cash Flow -38.56M
FCF Per Share -$4.18
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin -3,422.67%
Pretax Margin -3,012.27%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin -1,344.30%

Dividends & Yields

SABS does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -74.13%
Shareholder Yield -74.13%
Earnings Yield -159.41%
FCF Yield -134.88%

Analyst Forecast

The average price target for SABS is $12.40, which is 307.90% higher than the current price. The consensus rating is "Strong Buy".

Price Target $12.40
Price Target Difference 307.90%
Analyst Consensus Strong Buy
Analyst Count 5
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on January 5, 2024. It was a reverse split with a ratio of 0.1:1.

Last Split Date Jan 5, 2024
Split Type Reverse
Split Ratio 0.1:1

Scores

SABS has an Altman Z-Score of -4.16 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -4.16
Piotroski F-Score 2